White O, Dent S, Westbrook K, Lee HJ, et al. Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer. Breast Cancer Res Treat 2024 May 21. doi: 10.1007/s10549-024-07354.
PMID: 38771399